Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cross Country Healthcare (CCRN) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for Cross Country Healthcare (CCRN) over the last 16 years, with Q3 2025 value amounting to $243.1 million.

  • Cross Country Healthcare's Non-Current Assets fell 679.31% to $243.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $993.2 million, marking a year-over-year decrease of 552.71%. This contributed to the annual value of $254.3 million for FY2024, which is 376.17% down from last year.
  • Per Cross Country Healthcare's latest filing, its Non-Current Assets stood at $243.1 million for Q3 2025, which was down 679.31% from $244.8 million recorded in Q2 2025.
  • Cross Country Healthcare's Non-Current Assets' 5-year high stood at $272.2 million during Q4 2022, with a 5-year trough of $172.6 million in Q1 2021.
  • Moreover, its 5-year median value for Non-Current Assets was $251.0 million (2025), whereas its average is $241.9 million.
  • Its Non-Current Assets has fluctuated over the past 5 years, first crashed by 1208.56% in 2021, then skyrocketed by 2983.97% in 2022.
  • Quarter analysis of 5 years shows Cross Country Healthcare's Non-Current Assets stood at $224.5 million in 2021, then rose by 21.22% to $272.2 million in 2022, then fell by 2.94% to $264.2 million in 2023, then fell by 3.76% to $254.3 million in 2024, then fell by 4.38% to $243.1 million in 2025.
  • Its last three reported values are $243.1 million in Q3 2025, $244.8 million for Q2 2025, and $251.0 million during Q1 2025.